These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 17886255)

  • 1. Signaling by estrogens.
    Cheskis BJ; Greger JG; Nagpal S; Freedman LP
    J Cell Physiol; 2007 Dec; 213(3):610-7. PubMed ID: 17886255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogens and SERMs in coronary heart disease.
    Regitz-Zagrosek V; Wintermantel TM; Schubert C
    Curr Opin Pharmacol; 2007 Apr; 7(2):130-9. PubMed ID: 17317318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of selective estrogen receptor modulator (SERM) action.
    Dutertre M; Smith CL
    J Pharmacol Exp Ther; 2000 Nov; 295(2):431-7. PubMed ID: 11046073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Estrogen receptor subtypes and the regulatory effect of receptor ligand binding on gene transcription].
    An SJ; Zhang YX
    Sheng Li Ke Xue Jin Zhan; 2002 Oct; 33(4):309-12. PubMed ID: 12650065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance.
    Lewis JS; Jordan VC
    Mutat Res; 2005 Dec; 591(1-2):247-63. PubMed ID: 16083919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crossroads of estrogen receptor and NF-kappaB signaling.
    Biswas DK; Singh S; Shi Q; Pardee AB; Iglehart JD
    Sci STKE; 2005 Jun; 2005(288):pe27. PubMed ID: 15956359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selective estrogen receptor modulators: mechanisms of action and their tissue selectivity].
    Azuma K; Inoue S
    Clin Calcium; 2004 Oct; 14(10):12-26. PubMed ID: 15577127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular mechanism of tissue-specific actions of sex steroid hormones and SERM for bone remodeling].
    Kato S
    Clin Calcium; 2005 May; 15(5):825-30. PubMed ID: 15876746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective estrogen receptor modulators: an update on recent clinical findings.
    Shelly W; Draper MW; Krishnan V; Wong M; Jaffe RB
    Obstet Gynecol Surv; 2008 Mar; 63(3):163-81. PubMed ID: 18279543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
    Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
    J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective agonists of estrogen receptor isoforms: new perspectives for cardiovascular disease.
    Bolego C; Vegeto E; Pinna C; Maggi A; Cignarella A
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2192-9. PubMed ID: 16917104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates.
    Ho SM
    J Cell Biochem; 2004 Feb; 91(3):491-503. PubMed ID: 14755680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen genomic and membrane actions at an intersection.
    Arbogast LA
    Trends Endocrinol Metab; 2008 Jan; 19(1):1-2. PubMed ID: 18023201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coregulators in nuclear estrogen receptor action: from concept to therapeutic targeting.
    Hall JM; McDonnell DP
    Mol Interv; 2005 Dec; 5(6):343-57. PubMed ID: 16394250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptors: how do they signal and what are their targets.
    Heldring N; Pike A; Andersson S; Matthews J; Cheng G; Hartman J; Tujague M; Ström A; Treuter E; Warner M; Gustafsson JA
    Physiol Rev; 2007 Jul; 87(3):905-31. PubMed ID: 17615392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions.
    Cos S; González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ
    Cancer Detect Prev; 2006; 30(2):118-28. PubMed ID: 16647824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid estrogen actions in the cardiovascular system.
    Simoncini T; Mannella P; Genazzani AR
    Ann N Y Acad Sci; 2006 Nov; 1089():424-30. PubMed ID: 17261785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an ER action indicator mouse for the study of estrogens, selective ER modulators (SERMs), and Xenobiotics.
    Nagel SC; Hagelbarger JL; McDonnell DP
    Endocrinology; 2001 Nov; 142(11):4721-8. PubMed ID: 11606437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen signaling: An emanating therapeutic target for breast cancer treatment.
    Saha T; Makar S; Swetha R; Gutti G; Singh SK
    Eur J Med Chem; 2019 Sep; 177():116-143. PubMed ID: 31129450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential use of an estrogen-glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity.
    Maru BS; Tobias JH; Rivers C; Caunt CJ; Norman MR; McArdle CA
    Bone; 2009 Jan; 44(1):102-12. PubMed ID: 18976723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.